midostaurinantihistaminesportal hypertensionmast cell stabilisation therapySM-AHMchronic myelomonocytic leukaemia (CMML)
…reated with antihistamines, mast cell stabilisation therapy and midostaurin (a type III receptor tyrosine kinase inhibitor that inhibits D8…